Indal, Markhan A.

HRN: 26-57-68  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFTRIAXONE 1G (VIAL)
01/23/2025
01/30/2025
IV
175 Mg
Q 12
PCAP-C
Waiting Final Action 
01/26/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/26/2025
01/28/2025
PO
5ml
BID
Intestinal Parasitism
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: